コンテンツへスキップ
Merck
  • LINT, a novel dL(3)mbt-containing complex, represses malignant brain tumour signature genes.

LINT, a novel dL(3)mbt-containing complex, represses malignant brain tumour signature genes.

PLoS genetics (2012-05-10)
Karin Meier, Eve-Lyne Mathieu, Florian Finkernagel, L Maximilian Reuter, Maren Scharfe, Gunther Doehlemann, Michael Jarek, Alexander Brehm
要旨

Mutations in the l(3)mbt tumour suppressor result in overproliferation of Drosophila larval brains. Recently, the derepression of different gene classes in l(3)mbt mutants was shown to be causal for transformation. However, the molecular mechanisms of dL(3)mbt-mediated gene repression are not understood. Here, we identify LINT, the major dL(3)mbt complex of Drosophila. LINT has three core subunits-dL(3)mbt, dCoREST, and dLint-1-and is expressed in cell lines, embryos, and larval brain. Using genome-wide ChIP-Seq analysis, we show that dLint-1 binds close to the TSS of tumour-relevant target genes. Depletion of the LINT core subunits results in derepression of these genes. By contrast, histone deacetylase, histone methylase, and histone demethylase activities are not required to maintain repression. Our results support a direct role of LINT in the repression of brain tumour-relevant target genes by restricting promoter access.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
Anti-Dimethyl Histone H3 (Lys4) Antibody, clone CMA303, clone CMA303, from mouse
Sigma-Aldrich
ChIPAb+ Monomethyl-Histone H4 (Lys20) - ChIP Validated Antibody and Primer Set, from rabbit, purified by affinity chromatography